F.A. Helmond

2.2k total citations
51 papers, 1.7k citations indexed

About

F.A. Helmond is a scholar working on Small Animals, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, F.A. Helmond has authored 51 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Small Animals, 15 papers in Endocrinology, Diabetes and Metabolism and 14 papers in Genetics. Recurrent topics in F.A. Helmond's work include Animal Behavior and Welfare Studies (15 papers), Estrogen and related hormone effects (13 papers) and Menopause: Health Impacts and Treatments (12 papers). F.A. Helmond is often cited by papers focused on Animal Behavior and Welfare Studies (15 papers), Estrogen and related hormone effects (13 papers) and Menopause: Health Impacts and Treatments (12 papers). F.A. Helmond collaborates with scholars based in Netherlands, United States and Germany. F.A. Helmond's co-authors include V.M. Wiegant, B. Kemp, N.M. Soede, W.G.P. Schouten, F.H. de Jonge, Herjan J.T. Coelingh Bennink, E.A.M. Bokkers, P.R. Hein, Magnus Landgren and Steven Engelen and has published in prestigious journals such as Gastroenterology, The Journal of Clinical Endocrinology & Metabolism and Endocrinology.

In The Last Decade

F.A. Helmond

51 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F.A. Helmond Netherlands 29 615 577 451 351 223 51 1.7k
M.C. Veronesi Italy 26 526 0.9× 81 0.1× 853 1.9× 330 0.9× 266 1.2× 140 2.2k
Ian H. Thorneycroft United States 28 571 0.9× 735 1.3× 52 0.1× 101 0.3× 1.3k 5.7× 79 2.9k
O. D. Sherwood United States 38 249 0.4× 124 0.2× 179 0.4× 119 0.3× 209 0.9× 108 4.7k
Sergio C. Stone United States 22 207 0.3× 305 0.5× 54 0.1× 48 0.1× 997 4.5× 61 2.0k
W.T.K. Bosu United States 26 598 1.0× 118 0.2× 437 1.0× 241 0.7× 239 1.1× 72 1.8k
R.G. Elmore United States 24 535 0.9× 47 0.1× 221 0.5× 228 0.6× 205 0.9× 79 1.5k
Carl J. Pauerstein United States 25 187 0.3× 106 0.2× 45 0.1× 104 0.3× 695 3.1× 91 1.8k
C. Hernández Spain 25 167 0.3× 61 0.1× 399 0.9× 440 1.3× 17 0.1× 75 1.5k
Augusto Carluccio Italy 24 334 0.5× 54 0.1× 278 0.6× 156 0.4× 636 2.9× 108 1.5k
D. O. Rae United States 23 397 0.6× 46 0.1× 177 0.4× 212 0.6× 24 0.1× 72 1.7k

Countries citing papers authored by F.A. Helmond

Since Specialization
Citations

This map shows the geographic impact of F.A. Helmond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.A. Helmond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.A. Helmond more than expected).

Fields of papers citing papers by F.A. Helmond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.A. Helmond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.A. Helmond. The network helps show where F.A. Helmond may publish in the future.

Co-authorship network of co-authors of F.A. Helmond

This figure shows the co-authorship network connecting the top 25 collaborators of F.A. Helmond. A scholar is included among the top collaborators of F.A. Helmond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.A. Helmond. F.A. Helmond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Halperin, Scott A., Rituparna Das, Matthew Onorato, et al.. (2019). Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults. The Journal of Infectious Diseases. 220(7). 1127–1135. 34 indexed citations
2.
Halperin, Scott A., José Ramón Arribas, Richard Rupp, et al.. (2017). Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults. The Journal of Infectious Diseases. 215(12). 1789–1798. 56 indexed citations
3.
Marshall, Gary S., Shelly Senders, Darcy A. Hille, et al.. (2016). A double blind, randomized, active controlled study to assess the safety, tolerability and immunogenicity of measles, mumps rubella, and varicella vaccine (MMRV) manufactured using an alternative process. Human Vaccines & Immunotherapeutics. 12(8). 2188–2196. 3 indexed citations
4.
5.
Hospers, Geke A.P., F.A. Helmond, Erik F. J. de Vries, & Rudi Dierckx. (2008). PET Imaging of Steroid Receptor Expression in Breast and Prostate Cancer. Current Pharmaceutical Design. 14(28). 3020–3032. 24 indexed citations
6.
7.
Langer, Robert D., et al.. (2006). Effects of Tibolone and Continuous Combined Conjugated Equine Estrogen/Medroxyprogesterone Acetate on the Endometrium and Vaginal Bleeding: Results of the OPAL Study. American Journal of Obstetrics and Gynecology. 195(5). 1320–1327. 33 indexed citations
8.
Landgren, Magnus, F.A. Helmond, & Steven Engelen. (2004). Tibolone relieves climacteric symptoms in highly symptomatic women with at least seven hot flushes and sweats per day. Maturitas. 50(3). 222–230. 35 indexed citations
9.
Eckardstein, Arnold von, David Crook, Jolanda M. H. Elbers, et al.. (2003). Tibolone lowers high density lipoprotein cholesterol by increasing hepatic lipase activity but does not impair cholesterol efflux. Clinical Endocrinology. 58(1). 49–58. 30 indexed citations
10.
Wiegratz, Inka, et al.. (2002). Effect of tibolone compared with sequential hormone replacement therapy on carbohydrate metabolism in postmenopausal women. Maturitas. 41(2). 133–141. 11 indexed citations
11.
Huber, J., et al.. (2002). Effects of tibolone and continuous combined hormone replacement therapy on bleeding rates, quality of life and tolerability in postmenopausal women. BJOG An International Journal of Obstetrics & Gynaecology. 109(8). 886–893. 56 indexed citations
12.
Crook, David, Arnold von Eckardstein, Hans Dieplinger, et al.. (2000). Tibolone lowers plasma high density lipoprotein (HDL) concentrations but does not impair cholesterol efflux from cells. The Journal of the British Menopause Society. 6(2_suppl). 23–23. 1 indexed citations
13.
14.
Olsson, I. Anna S., F.H. de Jonge, T. Schuurman, & F.A. Helmond. (1999). Poor rearing conditions and social stress in pigs: repeated social challenge and the effect on behavioural and physiological responses to stressors. Behavioural Processes. 46(3). 201–215. 68 indexed citations
15.
Goozen, Stephanie H.M. van, V.M. Wiegant, Erik Endert, F.A. Helmond, & Nanne E. van de Poll. (1997). Psychoendocrinological Assessment of the Menstrual Cycle: The Relationship Between Hormones, Sexuality, and Mood. Archives of Sexual Behavior. 26(4). 359–382. 102 indexed citations
16.
Soede, N.M., F.A. Helmond, W.G.P. Schouten, & B. Kemp. (1997). Oestrus, ovulation and peri-ovulatory hormone profiles in tethered and loose-housed sows. Animal Reproduction Science. 46(1-2). 133–148. 28 indexed citations
17.
Helmond, F.A., et al.. (1995). Chronic stress and pituitary–adrenocortical responses to corticotropin-releasing hormone and vasopressin in female pigs. European Journal of Endocrinology. 132(4). 479–486. 28 indexed citations
18.
Helmond, F.A., et al.. (1994). Increased cortisol response to exogenous adrenocorticotropic hormone in chronically stressed pigs: influence of housing conditions. Journal of Animal Science. 72(7). 1771–1777. 68 indexed citations
19.
Schouten, W.G.P., et al.. (1994). Opioids and stereotypies in coping with chronic stress. Regulatory Peptides. 53. S237–S238. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.C. Veronesi Breakdown of academic impact, for papers by Ian H. Thorneycroft Breakdown of academic impact, for papers by O. D. Sherwood Breakdown of academic impact, for papers by Sergio C. Stone Breakdown of academic impact, for papers by W.T.K. Bosu Breakdown of academic impact, for papers by R.G. Elmore Breakdown of academic impact, for papers by Carl J. Pauerstein Breakdown of academic impact, for papers by C. Hernández Breakdown of academic impact, for papers by Augusto Carluccio Breakdown of academic impact, for papers by D. O. Rae
Rankless by CCL
2026